Evolus (EOLS) Current Assets (2017 - 2026)
Evolus' Current Assets was $201.74 million in Q3 2026, up 49.6% from $134.89 million a year earlier and up 20.4% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Evolus came in at $142.92 million, down 5.6% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- In earlier years, Current Assets was $151.34 million in FY2024 (+34.6%), $112.42 million in FY2023 (+11.5%), $100.8 million in FY2022 (-43.6%) and $178.8 million in FY2021 (+40.1%).
- The Q3 2026 figure marks the highest quarterly Current Assets in data going back to Q4 2017.
- Compared with a year earlier, Current Assets has increased for three straight quarters, with growth averaging 8.6% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q1 2022 (growth of 83.9%); the worst was Q4 2022 (a decline of 43.6%).
- Per Business Quant data, EOLS's Current Assets in the three quarters before Q3 2026 was $167.54 million (Q2 2026), $138.92 million (Q1 2026) and $142.92 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Evolus | 455.33 Mn | 264.84 Mn | 50.69 Mn | 201.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 201.74 Mn |
| Jun 30, 2026 | 167.54 Mn |
| Mar 31, 2026 | 138.92 Mn |
| Dec 31, 2025 | 142.92 Mn |
| Sep 30, 2025 | 134.89 Mn |
| Jun 30, 2025 | 144.97 Mn |
| Mar 31, 2025 | 131.72 Mn |
| Dec 31, 2024 | 151.34 Mn |
| Sep 30, 2024 | 150.36 Mn |
| Jun 30, 2024 | 158.13 Mn |
| Mar 31, 2024 | 150.27 Mn |
| Dec 31, 2023 | 112.42 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 96.46 Mn |
| Mar 31, 2023 | 84.09 Mn |
| Dec 31, 2022 | 100.80 Mn |
| Sep 30, 2022 | 115.95 Mn |
| Jun 30, 2022 | 133.95 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 178.80 Mn |
API Access
Evolus Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();